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Abstract
BACKGROUND: The onset of colorectal cancer 
appears to be two to three decades earlier in 
developing countries. Data on whether colorectal 
cancer in the young has worse prognosis than 
in older patients is conflicting.
METHOD: Clinical charts of 70 patients ≤40 
years old were reviewed to determine clinical 
and pathological patterns and treatment 
outcomes. Their data were compared with a 
larger group of older patients treated between 
1993-2005 at Kenyatta National Hospital in 
Nairobi, Kenya.
RESULTS: The data retrieval was highest 
for sub-site distribution and lowest for 
pathology information. Patients ≤ 40 years of 
age comprised 27.3% of all colorectal cancer 
cases treated over the study period. There 
were 41 males (58.6%) and 29 (41.4%) females 
patients. The most common symptoms were 
abdominal pain (76.9%), change in bowel habit 
(71.4%) and rectal bleeding (54.3%). The mean 
duration of symptoms was 24.6 ± 30 months. 
The rate of advanced colorectal disease (Duke 
C and D) was 73.5%. Mean follow-up time was 
5.8 months with median survival of only 6.9 
months. The Duke staging, histology, symptom 
duration, locations of tumours, follow-up and 
the complication rates were similar for young 
and older patients.
CONCLUSION: Younger patients form a 
significant proportion of  colorectal  cancer 
burden. Both the clinico-pathological 
characteristics and treatment outcome 
correspond to older individuals. It is suggested 
that the concluded colorectal symptoms in 
younger patients should also be aggressively 
evaluated including early endoscopy. A 
prospective follow-up study of patients with the 
disease will unravel the true survival picture.
Introduction
Colorectal cancer is the second most important 
cause of cancer mortality in men in the Western 
world (1). In these countries, the disease is 
predominantly in the older population with 
only a small proportion (1-8%) presenting 
in younger patients (2). It however remains 
debatable whether younger patients present in 
late stages of colorectal cancer and whether the 
disease in the young is more aggressive for a 
given stage of presentation (1).
A number of studies from the developing 
countries suggest the proportion of young 
patients may be up to six times that reported for 
Western literature (3-5). This report describes the 
clinical and pathological features of colorectal 
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cancer in patients ≤40 years old and compares 
the clinical, pathological and outcome variables 
of this group to older patients treated between 
1993-2005 at the same institution.
Patients and methods
Seventy patients aged 40 years and younger, 
and treated for colorectal cancer at the Kenyatta 
National Hospital (KNH) between 1993-2005, 
were reviewed. KNH is the main referral 
hospital in the city of Nairobi and serves as the 
teaching hospital for the University of Nairobi. 
All case notes for patients with histologically 
proven carcinoma of the colon and rectum were 
retrospectively analyzed. Information obtained 
included age, gender, education, ethnic group, 
location of colorectal cancer, symptoms, tumor 
pathology and stage, histology, and outcome 
data. The modifi ed Duke’s system was used 
to stage the tumour. The number of patients 
analyzed for specifi c variables was highest 
for site and lowest for pathology data (site 70, 
Dukes stage 34, tumour differentiation 56). The 
variables were compared for patients ≤40 years 
and those older.
The Kaplan Meir method was used to 
generate survival curves. Survival time was 
defi ned from the date of diagnosis to the date 
of death. Differences between young and old 
patients were analyzed statistically using the log 
rank test. P ≤ 0.05 was considered statistically 
signifi cant.
Results
In the 13-year period studied (1993-2005), 70 
patients ≤ 40 years old were diagnosed out of 
a total of 259 patients with colon and rectal 
adenocarcinoma. Forty one (58.6%) were male 
and 29 (41.4%) were female. The patients’ ages 
ranged from 10 to 40 years (mean = 30.1 ± 6.9 
years). Follow-up time ranged from 1.0 to 60.0 
months (mean = 5.8 ± 10.8 months). Most patients 
(95.7%) had received at least eight years of basic 
education (31 primary, 22 secondary and 13 
college/university education). Majority of the 
patients were from the Kikuyu ethnic group 
(37.1% n = 26). Other ethnic groups represented 
included the Kamba (14.3%, n = 10), Luhya (7.1%, 
n = 5) and Luo (18.6%, n = 13). The rest of the 
ethnic groupings constituted 22.9% (n = 16).
The duration of symptoms ranged from 
1 to 104 weeks (mean 24.6 ± 30). The most 
common presenting symptoms were abdominal 
pain (76.9%), change in bowel habit (71.4%), 
rectal bleeding (54.3%), swelling (34.8%), and 
tenesmus (17.1%), weight loss (14.3%) and 
bowel obstruction (14.3% , n = 10).
As shown in Figure 1, 50% of the tumors 
were located in the rectum, 17.1% in the sigmoid 
colon, 12.9% in the descending colon, 11.4% in 
cecum and 7.1% in ascending colon.
Pathology data were missing in many of the 
notes. Information on Duke stages was available 
for 34 patients. Majority were Duke stages C 
(n = 13) and D (n = 12). Well-differentiated or 
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moderately differentiated histology was present 
in 39 (69.6%) patients (Table 1).
Univariate analysis showed no overall 
survival difference between the differentiated 
and undifferentiated lesions in young patients 
(P>0.05). Outcome was also similar for gender, 
site of lesion, nature of surgery and stage of 
cancer (Table 2).
Although the comorbidity rate was higher 
for the older patients and the cancer was 
poorly differentiated in the younger patient, 
younger and older patients groups were 
similar for overall survival, stages of cancer, 
tumour location, complications and need for 
blood transfusion. They differed for rate of 
co-morbidity (higher in older patients) and 
proportion of poorly differentiated histology 
(higher in younger patients) (Table 3).
The follow up period was short (mean 
5.8 months, range one month to 5 years) with 
most patients lost to follow-up. There was 
no statistical difference between the follow 
up period for the young (5.8 ± 10 months) as 
compared to older patients (6.5 ± 9.0 months). 
Kaplan Meir analysis for survival depicted a 
mean overall survival of 6.9 months for patients 
≤40 years old and 9.4 months for older (log rank 
statistic 2.49, signifi cance 0.114). The survival 
trend for the two groups is shown in Figure 2.
Table 1: Clinical data for young CRC patients
Characteristic   No. of cases (%)
Gender Male 41 58.6
 Female 29 41.4
Comorbidity Yes 5 7.6
 No 61 92.4
Nature of surgery Elective 42 72.4
 Emergency 16 27.6
Adjuvant treatment Yes 29 42.6
 No 39 57.4
Duke stages A 3 8.8
 B 6 17.6
 C 13 38.2
 D 12 35.3
 No data/missing 36
Differentiation Well 21 37.5
 Moderate 18 32.1
 Poor 17 30.4
 No data/missing 14
Tumuor location caecum 8 11.6
 Ascending 5 7.2
 Descending 9 13.0
 Sigmoid 12 17.4
 Rectum 35 50.7
Symptoms Rectal bleeding 38 57.6
 Abdominal pain 50 76.9
 Altered bowel habit 45 71.4
 Weight loss 10 15.4
 Intestinal obstruction 10 15.4
 Abdominal swelling 23 34.8
 Tenesmus 12 18.8
Surgery performed Extended resection 22 32.4
 Palliative resection 6 8.8
 Stoma only 17 25.0
 Bypass 1 1.4
 APR 15 22.1
 Not operated 7 10.3
 Missing 2
Cases do not total 70 due to missing data
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Table 2: Outcome variables for colorectal cancer in young patients at KNH
No. of cases  No. of cases
Variable  Alive Dead p-value 
Gender Male 31 8 0.331
 Female 26 3
Stage Duke A/B 9 0 0.162
 Duke C/D 19 6
Nature of surgery Elective 37 4 0.099
 Emergency 11 5
Site of tumour Colon 29 5 0.742
 Rectum 28 6 
Differentiation Well/moderate 29 2 0.545
 Poor 17 1
*Statistic - Fischer’s exact test
Table 3: Comparison of colorectal cancer in older and the younger patient groups
Factor  Young Old p-value
Location of tumour Colon 34 78 0.380 
 Rectum 35 103
Comorbidity Present 5 37 0.014 
 Absent 61 139
Duke state A/B 9 27 0.673 
 C/D 25 62
Differentiation Well/Moderate 39 106 0.025
 Poor 17 20
Transfusion requirement Yes 46 116 0.330
 No 19 65
Complications Yes 21 47 0.452
 No 47 133
Status at last contact Alive 57 133 0.128
 Died 11 45
Figure 2: Survival functions
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Discussion
The seventy patients comprised 27.3% of all 
patients treated for colorectal cancer at this 
referral hospital between 1993 and 2005. This 
rate is much higher than available published 
results from the developed economies and some 
developing countries. Colorectal cancer in the 
young is reported to occur at a rate of 1-6% of 
all colorectal cancers among Americans (6,7). 
In a recent study from Istanbul, Turkey, Alici et 
al have reported a rate of 18% of 466 colorectal 
cancer cases over a 9 year period (8) while a 
similar rate was published from Iran (13.9%) 
(9). Our results extend previous data depicting 
an earlier onset of colorectal cancer in African 
populations as compared to Caucasian ones (3-
5). The explanation for this early development 
is not known.
The mean duration of symptom of 25 weeks 
and the high rate of advanced colorectal cancer 
was similar for young and older patients. It 
is unclear whether the delay is occasioned by 
the patient or the primary physician to whom 
the symptoms of abdominal pain, alteration 
of bowel habits or rectal bleeding are fi rst 
presented. The symptoms reported here are 
typical of other reports of colorectal cancer in 
the young. In the studies by Farner et al (10) and 
Kam et al (11) bleeding was the most common 
reported presentation in young people. Most of 
the young patients in our study had received at 
least eight years of formal education and could 
form an entry point for public education on 
the signifi cance of rectal bleeding as a possible 
initial symptom for rectal cancer.
In the current study, most tumours were 
located in the rectum. This distal distribution 
is however inconsistent with a number of 
published studies on young patients. Minardi 
et al found the disease to be evenly distributed 
throughout the colon and rectum in a Luisiana 
population (12) while Farner et al reported rectal 
distribution in one third of patients (10). Kam et 
al (11) reported a rectal distribution in 43% of 
Singaporean patients aged ≤30years. Tumours 
in patients with a predominant distal disease 
as in this study are expected to carry a better 
prognosis than those that arise more proximally. 
The diagnosis is usually late and the symptoms 
develop late in tumours proximal to the splenic 
fl exure (1). This appears not to be the case in 
our group of patients as the rate of advanced 
disease approached 73%.
There were no differences for patients 
younger or older than 40 years for stage, 
histology, sub-site distribution and transfusion 
requirements. These results are consistent 
with several previous reports (10) and do not 
support the conclusion that young age is a poor 
prognostic marker in colorectal cancer (13).
This study had limitations. Many sources of 
biases threaten the validity of results obtained in 
a retrospective study such as this one including 
missing data. Further symptom enquiries were 
not possible and details on family history 
and predisposing pathology known to play 
important role in the etiology of colorectal cancer 
in the young could not be established. The very 
short follow-up periods impact on the survival 
analysis as it is not possible to tell whether 
patients are lost to follow-up because of death 
or other socioeconomic reasons. This important 
aspect of post-treatment care is not unique to 
colorectal disease (14) and constitutes a serious 
threat to the external validity of the current 
results. Comparability with other long term 
series reporting on cohorts with long follow-
ups is remote. Prospective studies employing 
follow-up strategies different from the current 
chart review would present a better picture. 
Nonetheless, our results indicate that colorectal 
cancer in the younger age still occurs at advanced 
stages and the outcome for the short follow-up 
is poor. Efforts are recommended to ascertain 
the true survival pattern by improvements in 
follow-up and documentation.
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